{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T01:08:39Z","timestamp":1774314519801,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,5]]},"DOI":"10.7759\/cureus.100843","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T17:24:35Z","timestamp":1767633875000},"source":"Crossref","is-referenced-by-count":1,"title":["Iatrogenic Cushing\u2019s Syndrome and the Hidden Ingredient of Artri King"],"prefix":"10.7759","author":[{"given":"Basma","family":"Ataallah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Al Tameemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2018.33.2.139","article-title":"Recent updates on the diagnosis and management of Cushing's syndrome","volume":"33","author":"Nieman LK","year":"2018","unstructured":"Nieman LK. Recent updates on the diagnosis and management of Cushing's syndrome. Endocrinol Metab (Seoul). 2018, 33:139-46. 10.3803\/EnM.2018.33.2.139","journal-title":"Endocrinol Metab (Seoul)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/4769258","article-title":"A case of iatrogenic Cushing's syndrome following use of an over-the-counter arthritis supplement","volume":"2023","author":"Dunn C","year":"2023","unstructured":"Dunn C, Amaya J, Green P. A case of iatrogenic Cushing's syndrome following use of an over-the-counter arthritis supplement. Case Rep Endocrinol. 2023, 2023:4769258. 10.1155\/2023\/4769258","journal-title":"Case Rep Endocrinol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-7-41","article-title":"Cushing's disease","volume":"7","author":"Castinetti F","year":"2012","unstructured":"Castinetti F, Morange I, Conte-Devolx B, Brue T. Cushing's disease. Orphanet J Rare Dis. 2012, 7:41. 10.1186\/1750-1172-7-41","journal-title":"Orphanet J Rare Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline","volume":"93","author":"Nieman LK","year":"2008","unstructured":"Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2008, 93:1526-40. 10.1210\/jc.2008-0125","journal-title":"J Clin Endocrinol Metab"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jecr.2017.07.001","article-title":"Exogenous Cushing\u2019s syndrome secondary to intermittent high dose oral prednisone for presumed asthma exacerbations in the setting of multiple emergency department visits","volume":"6","author":"Manubolu S","year":"2017","unstructured":"Manubolu S, Nwosu O. Exogenous Cushing\u2019s syndrome secondary to intermittent high dose oral prednisone for presumed asthma exacerbations in the setting of multiple emergency department visits. J Clin Transl Endocrinol Case Rep. 2017, 6:4-8. 10.1016\/j.jecr.2017.07.001","journal-title":"J Clin Transl Endocrinol Case Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/2986312","article-title":"Co-occurrence of exogenous and endogenous Cushing's syndromes-dilemma in diagnosis","volume":"2019","author":"Tong CV","year":"2019","unstructured":"Tong CV, Rajoo S. Co-occurrence of exogenous and endogenous Cushing's syndromes-dilemma in diagnosis. Case Rep Endocrinol. 2019, 2019:2986312. 10.1155\/2019\/2986312","journal-title":"Case Rep Endocrinol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-1218","article-title":"Adrenal insufficiency in corticosteroids use: systematic review and meta-analysis","volume":"100","author":"Broersen LH","year":"2015","unstructured":"Broersen LH, Pereira AM, J\u00f8rgensen JO, Dekkers OM. Adrenal insufficiency in corticosteroids use: systematic review and meta-analysis. J Clin Endocrinol Metab. 2015, 100:2171-80. 10.1210\/jc.2015-1218","journal-title":"J Clin Endocrinol Metab"},{"key":"ref8","article-title":"Corticosteroid Adverse Effects","author":"Yasir M","year":"2025","unstructured":"Yasir M, Goyal A, Sonthalia S. Corticosteroid Adverse Effects. StatPearls Publishing, Treasure Island, FL; 2025."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-13-0036","article-title":"Too little or too much corticosteroid? Coexisting adrenal insufficiency and Cushing's syndrome from chronic, intermittent use of intranasal betamethasone","volume":"2013","author":"Dow A","year":"2013","unstructured":"Dow A, Yu R, Carmichael J. Too little or too much corticosteroid? Coexisting adrenal insufficiency and Cushing's syndrome from chronic, intermittent use of intranasal betamethasone. Endocrinol Diabetes Metab Case Rep. 2013, 2013:130036. 10.1530\/EDM-13-0036","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2005.01.013","article-title":"Exogenous Cushing's syndrome and glucocorticoid withdrawal","volume":"34","author":"Hopkins RL","year":"2005","unstructured":"Hopkins RL, Leinung MC. Exogenous Cushing's syndrome and glucocorticoid withdrawal. Endocrinol Metab Clin North Am. 2005, 34:371-84, ix. 10.1016\/j.ecl.2005.01.013","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref11","doi-asserted-by":"crossref","DOI":"10.1001\/archinte.1986.00360210246041","article-title":"Cushing's syndrome from the therapeutic use of intramuscular dexamethasone acetate","volume":"146","author":"Hughes JM","year":"1986","unstructured":"Hughes JM, Hichens M, Booze GW, Thorner MO. Cushing's syndrome from the therapeutic use of intramuscular dexamethasone acetate. Arch Intern Med. 1986, 146:1848-9.","journal-title":"Arch Intern Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4158\/EP.3.3.140","article-title":"Cushing'S syndrome attributable to topical use of lotrisone","volume":"3","author":"Weber SL","year":"1997","unstructured":"Weber SL. Cushing'S syndrome attributable to topical use of lotrisone. Endocr Pract. 1997, 3:140-4. 10.4158\/EP.3.3.140","journal-title":"Endocr Pract"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/8320254","article-title":"Iatrogenic Cushing's syndrome with subsequent adrenal insufficiency in a patient with psoriasis vulgaris using topical steroids","volume":"2017","author":"Pektas SD","year":"2017","unstructured":"Pektas SD, Dogan G, Cinar N. Iatrogenic Cushing's syndrome with subsequent adrenal insufficiency in a patient with psoriasis vulgaris using topical steroids. Case Rep Endocrinol. 2017, 2017:8320254. 10.1155\/2017\/8320254","journal-title":"Case Rep Endocrinol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1995.tb02603.x","article-title":"Megestrol-induced Cushing's syndrome","volume":"42","author":"Steer KA","year":"1995","unstructured":"Steer KA, Kurtz AB, Honour JW. Megestrol-induced Cushing's syndrome. Clin Endocrinol (Oxf). 1995, 42:91-3. 10.1111\/j.1365-2265.1995.tb02603.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1D222","article-title":"Cushing's syndrome due to interaction between inhaled corticosteroids and itraconazole","volume":"38","author":"Bolland MJ","year":"2004","unstructured":"Bolland MJ, Bagg W, Thomas MG, Lucas JA, Ticehurst R, Black PN. Cushing's syndrome due to interaction between inhaled corticosteroids and itraconazole. Ann Pharmacother. 2004, 38:46-9. 10.1345\/aph.1D222","journal-title":"Ann Pharmacother"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.41278","article-title":"Exogenous Cushing syndrome and hip fracture due to over-the-counter supplement (Artri King)","volume":"15","author":"Saad-Omer SM","year":"2023","unstructured":"Saad-Omer SM, Kinaan M, Matos M, Yau H. Exogenous Cushing syndrome and hip fracture due to over-the-counter supplement (Artri King). Cureus. 2023, 15:e41278. 10.7759\/cureus.41278","journal-title":"Cureus"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.aace.2022.08.001","article-title":"Exogenous Cushing syndrome caused by a \"herbal\" supplement","volume":"8","author":"Patel R","year":"2022","unstructured":"Patel R, Sherf S, Lai NB, Yu R. Exogenous Cushing syndrome caused by a \"herbal\" supplement. AACE Clin Case Rep. 2022, 8:239-42. 10.1016\/j.aace.2022.08.001","journal-title":"AACE Clin Case Rep"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2017.10.019","article-title":"Over-the-counter \"adrenal support\" supplements contain thyroid and steroid-based adrenal hormones","volume":"93","author":"Akturk HK","year":"2018","unstructured":"Akturk HK, Chindris AM, Hines JM, Singh RJ, Bernet VJ. Over-the-counter \"adrenal support\" supplements contain thyroid and steroid-based adrenal hormones. Mayo Clin Proc. 2018, 93:284-90. 10.1016\/j.mayocp.2017.10.019","journal-title":"Mayo Clin Proc"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.3337","article-title":"Unapproved pharmaceutical ingredients included in dietary supplements associated with US Food and Drug Administration warnings","volume":"1","author":"Tucker J","year":"2018","unstructured":"Tucker J, Fischer T, Upjohn L, Mazzera D, Kumar M. Unapproved pharmaceutical ingredients included in dietary supplements associated with US Food and Drug Administration warnings. JAMA Netw Open. 2018, 1:e183337. 10.1001\/jamanetworkopen.2018.3337","journal-title":"JAMA Netw Open"},{"key":"ref20","unstructured":"U.S. Food and Drug Administration. Public Notification. Artri King contains hidden drug ingredients. (2022). Accessed: December 18, 2025: https:\/\/www.fda.gov\/drugs\/medication-health-fraud\/public-notification-artri-king-contains-hidden-drug-ingredients."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/451949-iatrogenic-cushings-syndrome-and-the-hidden-ingredient-of-artri-king","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T17:24:36Z","timestamp":1767633876000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/451949-iatrogenic-cushings-syndrome-and-the-hidden-ingredient-of-artri-king"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.100843","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,5]]}}}